HKG:1177 Sino Biopharm

HKG:1177 Sino Biopharm operates in the field of Medicine. The Group’s business works in a fully integrated chain which spans from R&D to manufacture and sales of pharmaceutical products, covering a vast array of biopharmaceutical, chemical and modernized Chinese medicines. Interim result 2022 are favorable for dividends (+200%) yet EPS fell 77%

HKG:1177 Sino Biopharm

Last update: 18-Nov-23

Quick overview:

• • Yield: 3.13%

(See here Top 10 highest yield)

• • Lot: 1000
  • Price/Earnings ratio : 38.30 (Ideal <20 )
  • Earnings per share : 0.100 (Ideal >0.001)
  • Price as per 18-Nov-23 : HK$3.83
  • Ex-Dividend Date coming up:  N/A

See here all upcoming Ex-Dividend dates